Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06926543

Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy

Phase III Randomized Controlled Trial of Sequential Chemotherapy and Radiotherapy Versus Concurrent Chemoradiotherapy in Adjuvant Treatment of Breast Cancer (CONCERT)

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
858 (estimated)
Sponsor
Dr. Tabassum Wadasadawala · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical research aims to determine if concurrent chemotherapy and radiation therapy is more effective than sequential chemotherapy and radiation therapy for patients with stage IIB-III breast cancer. It seeks to answer the following key questions: 1. When compared to sequential treatment, does concurrent chemoradiotherapy increase disease-free survival? 2. What effects does concurrent treatment have on post-operative look, quality of life, and side effects including arm swelling (lymphoedema)? 3. What are each treatment approach's financial costs? Researchers will compare the following to groups: Arm A: Participants in the sequential treatment group will first undergo chemotherapy and then radiation. and Arm B: Participants in the concurrent treatment group will undergo radiation therapy while undergoing chemotherapy. Participants are going to: 1. Get the usual chemotherapy (taxanes and/or anthracyclines). 2. Receive radiation therapy for three to four weeks. 3. Have follow-up visits every 6months for 5years to check for cancer recurrence, side effects, and quality of life.

Conditions

Interventions

TypeNameDescription
DRUGChemoradiationThis intervention will consist of getting chemotherapy followed by radiotherapy, i.e, in a sequential manner
DRUGChemoradiationThis intervention will consist of getting chemotherapy and radiotherapy at the same time, i.e, in a concurrent manner.

Timeline

Start date
2024-05-14
Primary completion
2031-05-01
Completion
2031-05-01
First posted
2025-04-13
Last updated
2025-04-13

Locations

5 sites across 1 country: India

Source: ClinicalTrials.gov record NCT06926543. Inclusion in this directory is not an endorsement.